The invention relates to a novel
traditional Chinese medicine composition for treating diabetes class eyeground haemorrhage. The
traditional Chinese medicine composition comprises the following components: 3-9g of radix notoginseng
powder, 10-20g of red peony root, 20-40g of radix rehmanniae, 20-40g of medlar, 5-20g of angelica, 5-20g of radix sileris, 5-20g of
radix bupleuri, 20-40g of rhizoma atractylodis, 5-20g of white atractylodes
rhizome, 5-20g of plantain seed, 20-40g of
cassia seed, 20-40g of Chinese dodder, 5-20g of
equisetum, 5-20g of
periostracum cicadae, 20-40g of seed of job's
tears, 20-40g of glossy
privet fruit and 5-20g of notopterygium root. The components are heated, extracted or percolated by water or 30-90% of
ethanol, an extract is obtained after being purified, and then various preparations are prepared. The observation and the treatment of 218 cases of patients with diabetes class eyeground haemorrhage confirm that the invention has the functions of promoting
blood circulation, relieving the stasis of blood, removing heat from the liver and improving eyesight, can effectively enhance the vision of the patients and lowers the
relapse rate of the eyeground haemorrhage. By the clinical application, the invention is deeply popular with the patients, the clinical
curative effect reaches 77.42%, the
blindness causing rate is effectively reduced, the existence quality of patients with diabetes class
retina pathological changes is enhanced, and the invention fills the blank that China or even the world does not have
Chinese patent medicines for treating the eyeground haemorrhage.